Imperva Inc. (NYSE:IMPV) SVP Mark E. Kraynak sold 3,332 shares of the company’s stock in a transaction on Wednesday, November 16th. The shares were sold at an average price of $40.16, for a total transaction of $133,813.12. Following the completion of the transaction, the senior vice president now owns 448 shares of the company’s stock, valued at approximately $17,991.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Mark E. Kraynak also recently made the following trade(s):

  • On Friday, September 23rd, Mark E. Kraynak sold 5,582 shares of Imperva stock. The shares were sold at an average price of $51.00, for a total transaction of $284,682.00.

Shares of Imperva Inc. (NYSE:IMPV) traded down 0.62% on Thursday, reaching $40.00. 257,812 shares of the company’s stock were exchanged. The company’s market capitalization is $1.31 billion. Imperva Inc. has a 1-year low of $31.11 and a 1-year high of $77.99. The stock’s 50-day moving average price is $43.60 and its 200-day moving average price is $43.25.

Imperva (NYSE:IMPV) last announced its quarterly earnings data on Thursday, November 3rd. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.24. Imperva had a negative net margin of 25.60% and a negative return on equity of 28.37%. The business earned $68.40 million during the quarter, compared to the consensus estimate of $63.10 million. During the same quarter in the prior year, the firm earned $0.19 EPS. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. Analysts anticipate that Imperva Inc. will post ($0.39) EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Imperva (NYSE:IMPV)

IMPV has been the subject of several recent research reports. Buckingham Research reiterated a “neutral” rating and set a $45.00 target price on shares of Imperva in a research note on Saturday, October 22nd. Pacific Crest reiterated a “buy” rating and set a $57.00 target price on shares of Imperva in a research note on Friday, August 5th. Evercore ISI upgraded shares of Imperva from a “hold” rating to a “buy” rating in a research note on Friday, November 4th. Imperial Capital reiterated an “outperform” rating and set a $50.00 target price on shares of Imperva in a research note on Wednesday, November 9th. Finally, RBC Capital Markets reiterated a “buy” rating and set a $52.00 target price (up previously from $49.00) on shares of Imperva in a research note on Friday, August 5th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. Imperva currently has a consensus rating of “Buy” and an average price target of $49.69.

Several large investors have recently made changes to their positions in IMPV. Vanguard Group Inc. increased its stake in shares of Imperva by 8.7% in the second quarter. Vanguard Group Inc. now owns 2,077,265 shares of the company’s stock worth $89,343,000 after buying an additional 165,851 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Imperva by 3.9% in the second quarter. JPMorgan Chase & Co. now owns 1,536,698 shares of the company’s stock worth $66,092,000 after buying an additional 57,686 shares in the last quarter. Credit Suisse AG increased its stake in shares of Imperva by 865.9% in the second quarter. Credit Suisse AG now owns 1,431,447 shares of the company’s stock worth $61,568,000 after buying an additional 1,283,243 shares in the last quarter. Eagle Asset Management Inc. increased its stake in shares of Imperva by 3.1% in the second quarter. Eagle Asset Management Inc. now owns 1,338,055 shares of the company’s stock worth $57,549,000 after buying an additional 40,709 shares in the last quarter. Finally, Litespeed Management L.L.C. increased its stake in shares of Imperva by 893.6% in the third quarter. Litespeed Management L.L.C. now owns 943,915 shares of the company’s stock worth $50,698,000 after buying an additional 848,915 shares in the last quarter. 87.53% of the stock is owned by institutional investors and hedge funds.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.

5 Day Chart for NYSE:IMPV

Receive News & Stock Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related stocks with our FREE daily email newsletter.